Today’s high-speed PCB and system-level design demands fast, accurate simulation. This ebook explains how to choose the right ...
In this excerpt from the new book 'Speak Data,' the Wharton professor and best-selling author shares his thoughts on how we ...
Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback